Advice
following an abbreviated submission
glatiramer acetate 40mg/mL (Copaxone®) is accepted for use within NHS Scotland.
Indication under review: treatment of relapsing forms of multiple sclerosis (MS).
This new formulation of glatiramer acetate (40mg/ml) given three times a week costs the same as the currently available formulation (glatiramer acetate 20mg/ml) that is given daily.
Download detailed advice100KB (PDF)
Medicine details
- Medicine name:
- glatiramer acetate (Copaxone)
- SMC ID:
- 1108/15
- Indication:
- treatment of relapsing forms of multiple sclerosis (MS).
- Pharmaceutical company
- Teva UK Limited
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 December 2015